LoF variants resulting in a 50% reduction of TBK1, could explain 0.4–3.4% of ALS, 0.2–1.3% of FTD and 3.3–4.5% of FTD–ALS [22]. This evidence concerns the gene TBK1 and amyotrophic lateral sclerosis.